CA125 and ovarian cancer: When should it and when should it not be measured?
Please note that for mobiles we stream the presentation slides and audio of the speaker.
You must login to watch this lecture.
This video has been archived as it is more than 2 years old. CPD is no longer available.
In this lecture, Gordon Rustin debates the benefits of diagnosing ovarian cancer early. Does early diagnosis in fact cause more harm to patients? And does measuring tumour progression according to CA125 help patients? Rustin weighs up the pros and cons and explains why patients and doctors continue routine CA125 measurements.
This lecture was part of an event called "Ovarian cancer, the Leah Lederman lecture and Annual General Meeting" at The Royal Society of Medicine in London.
Date of lecture:25th September 2013
This video is available for iPad via Safari.
Tips about RSM Videos
- This video is free to view for RSM Members, please log in before watching. There is a fee of £6.00 for Non-Members.
- The CPD process for this video has now expired. Previously booked CPD credits can still be accessed after login.
- Click on the Slides tab to view all slides. You can make any slide larger by clicking on it.
- Click on the Chapters tab to view different parts of the video.